Nurix Therapeutics (NRIX) Net Cash Flow (QoQ) (2020 - 2026)
Powered by 
Analysis
Nurix Therapeutics (NRIX) Net Cash Flow (QoQ) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 10 | Nurix Therapeutics | 2.86 Bn | 2.42 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 98.00% |
| Feb 28, 2026 | -204.30% |
| Nov 30, 2025 | 3,028.27% |
| Aug 31, 2025 | -168.97% |
| May 31, 2025 | 124.48% |
| Feb 28, 2025 | -411.16% |
| Nov 30, 2024 | 161.72% |
| Aug 31, 2024 | -126.50% |
| May 31, 2024 | 1,491.30% |
| Feb 29, 2024 | -139.07% |
| Nov 30, 2023 | 173.99% |
| Aug 31, 2023 | -165.60% |
| May 31, 2023 | 182.15% |
| Feb 28, 2023 | -282.66% |
| Nov 30, 2022 | 180.89% |
| Aug 31, 2022 | 116.17% |
| May 31, 2022 | -3,252.57% |
| Feb 28, 2022 | 98.34% |
| Nov 30, 2021 | -64.66% |
| Aug 31, 2021 | -165.75% |